Perception and practice of self-medication with antibiotics among medical students in Sudanese universities : A cross-sectional study

INTRODUCTION: The benefits of antibiotics are under threat by self-medication, which culminated in economic burdening of developing countries, treatment failures, the emergence of antibiotic-resistant strains of bacteria and an increased probability of exposure and infection of the general population by antibiotic-resistant bacterial strains.

OBJECTIVES: This study aimed to evaluate the knowledge and attitude of medical students in Sudan towards the use of antibiotics, the prevalence of self-medication with antibiotics among medical students in Sudan and to identify risk factors which promote self-medication with antibiotics.

MATERIALS AND METHODS: This was a cross-sectional, descriptive and institution-based study, between November 2020 and May 2021. 1,110 medical students were selected by multistage cluster sampling. Logistic regression was used to identify risk factors of self-medication with antibiotics among the study participants.

RESULTS: The median knowledge score was 7 out of a maximum of 10 (IQR: 5-8). A moderately positive attitude was observed among the participants (Median: 7/10; IQR: 6-8). Knowledge and attitude scores were significantly associated with academic year and monthly allowance (p < 0.05). 675 (60.8%) self-medicated with antibiotics within the previous 12 months, mostly from community pharmacies (321/675; 47.5%). Antibiotics were most commonly used to treat respiratory tract infections (38.1%) and cough (30.4%). Chi-square analysis demonstrated that self-medication with antibiotics was significantly associated with gender, year of study and monthly income.

CONCLUSIONS: Undergraduate medical students had moderate knowledge and attitude towards antibiotic use and antibiotic resistance, and an alarmingly high prevalence of self-medication with antibiotics. This highlights the urgent need for tighter legislation regarding the sales of antibiotics in community pharmacies by the state and federal health ministries.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

PloS one - 17(2022), 1 vom: 06., Seite e0263067

Sprache:

Englisch

Beteiligte Personen:

Elmahi, Osman Kamal Osman [VerfasserIn]
Musa, Reem Abdalla Elsiddig [VerfasserIn]
Shareef, Ahd Alaaeldin Hussain [VerfasserIn]
Omer, Mohammed Eltahier Abdalla [VerfasserIn]
Elmahi, Mugahid Awad Mohamed [VerfasserIn]
Altamih, Randa Ahmed Abdalrheem [VerfasserIn]
Mohamed, Rayan Ibrahim Hamid [VerfasserIn]
Alsadig, Tagwa Faisal Mohamed [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Clinical Trial
Journal Article
Multicenter Study

Anmerkungen:

Date Completed 21.02.2022

Date Revised 21.02.2022

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0263067

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336155603